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Glycine receptors (GlyRs) and specific subtypes of GABAA receptors are clustered at synapses by the multidomain protein gephyrin,
whichinturnistranslocatedtothecellmembranebytheGDP–GTPexchangefactorcollybistin.Wereportthecharacterizationofseveral
newvariantsofcollybistin,whicharecreatedbyalternativesplicingofexonsencodinganN-terminalsrchomology3(SH3)domainand
threealternateCtermini(CB1,CB2,andCB3).ThepresenceoftheSH3domainnegativelyregulatestheabilityofcollybistintotranslocate
gephyrintosubmembranemicroaggregatesintransfectedmammaliancells.Becausethemajorityofnativecollybistinisoformsappear
toharbortheSH3domain,thissuggeststhatcollybistinactivitymayberegulatedbyprotein–proteininteractionsattheSH3domain.We
localized the binding sites for collybistin and the GlyR subunit to the C-terminal MoeA homology domain of gephyrin and show that
multimerizationofthisdomainisrequiredforcollybistin–gephyrinandGlyR–gephyrininteractions.Wealsodemonstratethatgephy-
rin clustering in recombinant systems and cultured neurons requires both collybistin–gephyrin interactions and an intact collybistin
pleckstrin homology domain. The vital importance of collybistin for inhibitory synaptogenesis is underlined by the discovery of a
mutation (G55A) in exon 2 of the human collybistin gene (ARHGEF9) in a patient with clinical symptoms of both hyperekplexia and
epilepsy.Theclinicalmanifestationofthiscollybistinmissensemutationmayresult,atleastinpart,frommislocalizationofgephyrinand
amajorGABAAreceptorsubtype.
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Introduction
Inhibitory neurotransmission relies on glycine and GABA recep-
torsbeingclusteredatpostsynapticspecializationsoppositeaxon
terminals releasing the corresponding neurotransmitters. Cen-
tral to this arrangement is gephyrin, which colocalizes with gly-
cine receptors (GlyRs) at inhibitory synapses (Triller et al., 1985;
Schmitt et al., 1987). Gephyrin can interact with polymerized
tubulin (Kirsch et al., 1991), the GlyR  subunit (Kneussel et al.,
1999a), profilin (Mammoto et al., 1998), RAFT-1 (rapamycin
and FKBP target-1) (Sabatini et al., 1999), dynein light chains 1
and2(Fuhrmannetal.,2002),andMena(mammalianenabled)/
VASP (vasodilator stimulated phosphoprotein) (Giesemann et
al., 2003). In addition, gephyrin is also essential for the postsyn-
aptic clustering of GABAA receptors containing 2o r3 sub-
units(Essrichetal.,1998;Kneusseletal.,1999b,2001b;Levietal.,
2004).AselectivelossofsynapticGABAAreceptorsin2subunit
mutant mice also results in the loss of gephyrin clusters (Essrich
et al., 1998; Schweizer et al., 2003), indicating some interdepen-
dence for their synaptic localization. Interestingly, when ex-
pressed in mammalian cells, gephyrin forms cytoplasmic aggre-
gates (Kirsch et al., 1995), suggesting that other “factors” are
required to direct gephyrin to submembrane microaggregates.
The preliminary characterization of collybistin (Kins et al., 2000;
Grosskreutzetal.,2001),anovelgephyrin-associatedGDP–GTP
exchange factor (GEF), presented a plausible mechanism(s) by
which gephyrin could be targeted to synapses.
Collybistin is a member of the guanine nucleotide exchange
factorsuperfamily,whichcatalyzesGDP–GTPexchangeonsmall
GTPases of the Rho family (Wherlock and Mellor, 2002). GEFs
are characterized by tandem exchange factor (RhoGEF) and
pleckstrin homology (PH) domains. The RhoGEF domain cata-
lyzes the exchange reaction, whereas the PH domain can bind
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ing GEF localization and activity to the submembrane compart-
ment (Kavran et al., 1998). Collybistin was initially found in two
isoforms created by alternative splicing: “collybistin I,” which
contains an N-terminal src homology 3 (SH3) domain and a
C-terminal coiled-coil domain, and “collybistin II,” which lacks
the SH3 domain and has an alternate C terminus. On expression
in human embryonic kidney (HEK) 293 cells, collybistin I colo-
calizedwithintracellulargephyrinaggregates,whereascollybistin
II enabled translocation of gephyrin to submembrane microag-
gregates (Kins et al., 2000). The human homolog of collybistin,
hPEM-2 (human homolog of Posterior End Mark-2), appears to
activate the GTPase Cdc42 (Reid et al., 1999), which influences
cell morphology by initiating actin cytoskeleton remodeling
(EricksonandCerione,2001).Ithasbeenproposedthatatinhib-
itory synapses, collybistin initiates local remodeling of the sub-
synaptic cytoskeleton (Kneussel and Betz, 2000).
In this study, we investigated the diversity of collybistin iso-
forms generated by alternative splicing and the role of the SH3,
RhoGEF,andPHdomainsintranslocatinggephyrintosubmem-
brane microaggregates. We also mapped the binding sites for
collybistinandtheGlyRsubunitongephyrin.Thisinformation
was used to evaluate ARHGEF9 as a candidate gene for hyperek-
plexiainacohortof32patientswithoutmutationsintheGlyR1
and  subunit genes or gephyrin (Rees et al., 2001, 2002, 2003).
Examination of naturally occurring and artificial mutants of col-
lybistin emphasizes the importance of this RhoGEF for postsyn-
aptic localization of gephyrin and inhibitory ligand-gated ion
channels.
MaterialsandMethods
Amplification, cloning, and sequencing of rat and human collybistin
cDNAs. Rat collybistin cDNAs were amplified from postnatal day (P) 0
ratspinalcordandwhole-brainfirst-strandcDNAusingtheprimercombi-
nations r1: 5-GTGGGATCCATGCAGTGGATTAGAGGCGGA-3 plus
r2: 5-TTCGAATTCCCCATCCTCCTGGTTCACCCA-3and r3 5-GGA-
GGATCCAATACGTTGGCTTAGAGCTTT-3 plus r4 5-TTAGAA-
TTCTCTGCCTTCCTATAGGTATTA-3. Human collybistin cDNAs
were amplified from human whole-brain or spinal cord cDNA (Clontech,
Cambridge, UK) using the primer combinations h1: 5-CATGGCCTCG-
CTGTGATATGTATG-3 plus h2: 5-TCCAGGTGTCCGTTCTGCAC-
ATCG-3 or h3 5-CTGCAATGACTGTGAGAAAAGTCC-3 plus h4
5-ATTATCTGCCTCCCTGTAGGTATC-3. Amplifications were per-
formedundersemiquantitativeconditionsusingPfuTurboproofreading
DNA polymerase (Stratagene, La Jolla, CA) and 30 cycles of 94°C for 1
min,65°Cfor1min,and68°Cfor3min.PCRproductswereclonedinto
the pCR4 Blunt TOPO vector (Invitrogen, San Diego, CA), and plasmid
DNAs were made using spin miniprep and maxi kits (Qiagen, Hilden,
Germany). Plasmid inserts were fully sequenced using the BigDye ready
reactionmix(PerkinElmerLifeSciences,Emeryville,CA)andanApplied
Biosystems (Foster City, CA) 310 automated DNA Sequencer.
Functional assays of collybistin–gephyrin interactions in HEK293 cells.
pRK5myc-CB2SH3, pRK5myc-CB2SH3, and pRK5myc-CB3SH3: colly-
bistin cDNAs were amplified from P0 rat brain first-strand cDNA using
the primers r1 and r4 (see above) and cloned into the BamHI and EcoRI
sites of the vector pRK5myc so that a 9E10 (myc) tag is attached to the N
terminus.DeletionsoftheSH3,RhoGEF,andPHdomainsweremadein
pRK5myc-CB2SH3 using the Quikchange site directed mutagenesis kit
(Stratagene). pEGFP-gephyrin: the entire coding region of the rat gephy-
rin P1 isoform (Prior et al., 1992) was amplified from P0 rat brain first-
strand cDNA using the primers rGeph1 5-CGCTGATCAACAT-
GGCGACCGAGGGA-3 and rGeph2 5-TGGCTCGAGTCATAGCC-
GTCCGATGA-3, cut with BclI and XhoI, and cloned into the BglII and
SalI sites of pEGFP-C2 (Clontech), so that the enhanced green fluores-
cent protein (EGFP) tag is N terminal. pDsRed-GlyR : the large intra-
cellular loop of the human GlyR  subunit (Handford et al., 1996) was
amplified using the primers hDsRed1 5-GCTGAATTCGCCAC-
CATGGCAGTTGTCCAGGTGATGCT-3 and hDsRed2 5-AAC-
GGATCCCTTGCATAAAGATCAATTCGC-3 and cloned into the
EcoRIandBamHIsitesofpDSRedN1(Clontech),sothattheDsRedtagis
C terminal. Amplifications were performed using Pfu Turbo DNA poly-
merase, and all plasmids were sequenced to confirm the veracity of the
constructs.HEK293cells(CRL1573;AmericanTypeCultureCollection,
Manassas,VA)weregrowninDMEMsupplementedwith10%(v/v)fetal
bovine serum (FBS), 2 mM glutamine, 100U/ml penicillin G, and 100
g/ml streptomycin at 37°C in 95% air–5% CO2 (Harvey et al., 1999).
Exponentially growing cells were electroporated (400 V; infinite resis-
tance, 125 F; Gene Electropulser II; Bio-Rad, Hercules, CA) with vari-
ous combinations of the plasmid constructs. For cotransfections (e.g.,
myc-CB2SH3plusEGFP-gephyrin),plasmidswereusedataratioof1:1.
After 24 hr, cells were washed twice in PBS and fixed for 5 min in 4%
(w/v) paraformaldehyde (PFA) in PBS. Myc-tagged CB2SH3, CB2SH3,
and CB3SH3 proteins were detected using an anti-9E10 monoclonal anti-
body (mAb) (Sigma, St. Louis, MO) and tetramethylrhodamine
isothiocyanate- or cyanin 5 (Cy5)-conjugated secondary antibodies
(Jackson ImmunoResearch, West Grove, PA) using standard protocols.
Confocal microscopy was performed as described previously (Dunne
et al., 2002).
Culture, transfection, and immunostaining of cortical neurons. Cortical
neurons were cultured from embryonic day (E) 14 mice. Cortical hemi-
spheres were collected in PBS, pH 7.4, containing 5.5 mM glucose and
treated with papain (0.5 mg/ml; Sigma) and DNase I (10 g/ml) in PBS
containing1mg/mlbovineserumalbuminand10mMglucosefor15min
at room temperature. The cells were mechanically triturated and then
plated on poly-L-lysine-coated glass coverslips at 4  10
4 cells/cm
2 in
modified Eagle medium (Invitrogen) containing 10% (v/v) FBS, which
was replaced after 60 min. After 24 hr, the coverslips were turned upside
down onto a glial feeder layer in a Petri dish containing Neurobasal-A
supplementedwithB27(Invitrogen).Neuronsweretransfectedat18din
vitro (DIV) using a calcium coprecipitation transfection kit (BD Bio-
sciences,PaloAlto,CA).Briefly,thecoverslipswerereinvertedandtrans-
ferred into new Petri dishes containing glia-conditioned Neurobasal
A/B27 supplemented with 0.8 mg/ml NaHCO3,1M 6-cyano-7-
nitoquinoxaline-2,3-dione (Sigma), and 100 M 2-amino-5-phospho-
novaleric acid (Sigma). Plasmid DNA (10 g/coverslip) was mixed with
12.4lof2MCaCl2toafinalvolumeof100 landthenaddedslowlyto
anequalvolumeof2HEPES-bufferedsalinewhilethoroughlymixing.
The DNA was allowed to precipitate for 15 min, added to the cells, and
incubated for 45 min. The coverslips were then returned to the original
dishescontainingconditionedmediumandusedforimmunocytochem-
istry at 21 DIV.
NeuronsoncoverslipswererinsedwithPBS,fixedwith4%(w/v)PFA
in 150 mM sodium phosphate buffer, pH 7.4, for 15 min, permeabilized
for 5 min with 0.15% saponin in PBS containing 10% (v/v) normal
donkey serum, and incubated overnight at 4°C with combinations of
primary antibody to the myc tag of collybistin constructs (rabbit poly-
clonal anti-Myc Tag; Medical and Biological Laboratories, Nahgoya, Ja-
pan), gephyrin (mAb7a; Alexis Biochemicals, San Diego, CA), or glu-
tamic acid decarboxylase (mAb GAD-6; Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City, IA) and the GABAA
receptor 2 subunit (raised in guinea pigs) (Fritschy and Mohler, 1995)
in PBS containing 0.15% (v/v) saponin and 10% (v/v) normal donkey
serum. Note that for experiments with EGFP-gephyrin constructs,
mAb7a is assumed to recognize both native and recombinant gephyrin.
The cells were washed in PBS containing 0.15% (v/v) saponin and then
incubatedwithsecondaryantibodyraisedintheproperspeciesandcon-
jugated to AlexaFluor 488 (Molecular Probes, Eugene, OR), Cy3, or Cy5
(Jackson ImmunoResearch) in PBS containing 0.15% (v/v) saponin and
10% (v/v) normal donkey serum. Epifluorescent images were captured
using a Zeiss (Thornwood, NY) Axiophot2 microscope equipped with a
1.3 differential interference contrast 40 objective and an ORCA-100
cooledCCDcameralinkedtoanOpenlabimagingsystem(Improvision,
Lexington, MA).
Quantitation of immunofluorescence images. To quantify the effects of
transfectingwild-typeormutantcollybistinandgephyrinconstructsinto
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(for 10–12 transfected cells per construct) that exhibited low overall
background staining for gephyrin (mAb7a) or the GABAA receptor 2
subunit. Immunoreactive puncta (size range, 0.2–2 m in diameter) in
eachsegmentwereautomaticallyselectedbysettingafluorescenceinten-
sity threshold that was twofold greater than the diffuse fluorescence on
dendritic shafts within the region of interest. The average number of
gephyrin (mAb7a) clusters was determined by counting the number of
immunoreactivepunctawithinthecorrectsizerangeper40msegment
percell.ThenumberofGABAAreceptorclusters(punctate2immuno-
reactivity) was determined identically on dendritic segments that were
innervated by GABAergic terminals (as judged by GAD staining). Anal-
ysis was performed using Openlab imaging software with Microsoft (Se-
attle, WA) Excel. Student’s two-tailed t test was used for all statistical
comparisons.
MappingbindingsitesongephyrinusingtheGAL4yeasttwo-hybridsystem.
To identify putative domains of gephyrin, which interact with the colly-
bistin and the GlyR  subunit, several baits were cloned into the GAL4
bindingdomainvectorpYTH9,whichcanbeintegratedintothetrplocus
for stable expression of fusion proteins (Fuller et al., 1998). pYTH9-
CB2SH3:pRK5myc-CB2SH3wascutwithNcoIandEcoRItoreleasethe
full-length cDNA, and this was cloned into the corresponding sites in
pYTH9.pYTH9-GlyR:thelargeintracellularloopofthehumanGlyR
subunit (Handford et al., 1996) was amplified using the primers hGlyR1
5-GGTGTCGACGAACAACCCCAAAAGGGTTGA-3 and hGlyR2
5-AGGGAATTCTCATCTTGCATAAAGATCAAT-3and cloned into the
SalI and EcoRI sites of pYTH9. pYTH9-MoeA: the “MoeA homology do-
main” from the rat gephyrin P1 isoform (Prior et al., 1992) was amplified
usingtheprimersrGeph35-AGCGTCGACCAGTGCTGTAGATATCA-3
and rGeph4 5-TGGCCGCGGTCATAGCCGTCCGATGACCA-3 and
clonedintotheSalIandSacIIsitesofpYTH9.Fragmentsoftheratgephyrin
P1 isoform cDNA were amplified using multiple oligonucleotide primers
andwereclonedintothevectorpACT2(Clontech).Asabove,amplifications
were performed using Pfu Turbo DNA polymerase, and all constructs were
fully sequenced. Cotransformed yeast were plated on selective dropout me-
dia lacking leucine and tryptophan (Clontech) and incubated at 30°C for
3–6 d to allow prototropic colonies to emerge. LacZ reporter gene assays
were performed as described previously (Fuller et al., 1998).
Collybistin gene structures and analysis in hyperekplexia patients. Hu-
man collybistin cDNAs (Reid et al., 1999; our study) were submitted for
BasicLocalAlignmentSearchTool(BLAST)-likealignmenttoolsearches
of the University of California Santa Cruz Genome Browser Database
(Karolchik et al., 2003) (http://genome.ucsc.edu/). Intron–exon organi-
zations were established from comparisons of cloned cDNAs, spliced
expressed sequence tags (ESTs) and genomic sequences. The majority of
patients included in the mutation analysis of the human collybistin gene
(ARHGEF9) are described previously (Rees et al., 2001). An additional
sevenunrelatedhyperekplexiapatientswerealsoanalyzed;allconformto
the diagnostic criteria of inclusion, which involves a history of neonatal
hypertonia, a nose tap response, and an exaggerated startle response
leading to injurious fall down consequences with preservation of con-
sciousness (Andrew and Owen, 1997). Exons and flanking intronic se-
quences,plus5and3untranslatedregions,wereamplifiedfrompatient
DNAs using the primers detailed in supplemental Table 1 (available at
www.jneurosci.org) (Rees et al., 2001, 2002). Each 25 l reaction con-
tained60ngofgenomicDNA,10pmolofeachprimer,1.5mMMgCl2,50
mM KCl, 10 mM Tris-HCl, pH 8.3, 200 M dNTPs (Amersham Bio-
sciences,ArlingtonHeights,IL),and1UTaqpolymerase(Qiagen).PCR
conditionsconsistedofaninitialdenaturationat94°Cfor5minfollowed
by35cyclesof30secat94°C,30secat60°C,and30secat72°C.Mutation
analysis of PCR products was performed using Transgenomic dHPLC
HT-WAVE
RDNAFragmentAnalysisSystem,usingDNASep
Rcolumns
(Transgenomic, Omaha, NE). The program dHPLCMelt was used to
predict the optimal melting conditions for PCR fragments, and the
WAVE instrument was run under partially denaturing conditions for
mutation detection and single-nucleotide polymorphism (SNP) discov-
ery. Because of the X-linked localization of ARHGEF9, all male patient
PCRs were combined with a sequence-verified female DNA control.
Variant dHPLC profiles suggestive of allelic heterogeneity were gel iso-
lated (Qiagen) and sequenced using ABI3100 technology. The G55A
mutant was introduced into pRK5myc-CB3SH3 using the Quikchange
site-directed mutagenesis kit (Stratagene).
Results
Multiple collybistin isoforms are generated by
alternative splicing
Yeast two-hybrid screening with gephyrin originally identified
two collybistin isoforms, which were created by alternative splic-
ing of primary transcripts (Kins et al., 2000). Alternative splicing
of collybistin mRNAs appears to have functional relevance, be-
cause only collybistin II is able to translocate gephyrin to sub-
membranous microaggregates (Kins et al., 2000). We performed
reverse transcriptase (RT)-PCR assays from rodent–human spi-
nalcordandwhole-braincDNAstoassesstherelativeabundance
of different collybistin transcripts. DNA sequence analysis of
both amplified and published cDNAs (Kins et al., 2000) revealed
thatthreedifferentcollybistinCterminicanbespecifiedintherat
by the use of different cassette exons (Fig. 1A–D). Collybistin I
(GRVGEEENQSLELKRACEVLQRLWSPGKKS*) and collybis-
tin II (VTQRKWHY*) C termini are generated by insertion of
either109or62bpexonsintocollybistintranscripts(Fig.1A,C).
Whenneitherexonisused,athirdCterminusisspecified,which
shares 59 of 60 residues with the C terminus of human colly-
bistin (hPEM-2) (Reid et al., 1999). In contrast, the exon en-
coding the N-terminal SH3 domain is used in the majority of
rodent and human collybistin brain mRNAs (Fig. 1B). Splic-
ing of this exon did not alter during postnatal development in
mouse brain (Fig. 1B).
Accordingly,werenamedthesecollybistinisoformsCB1(col-
lybistin I), CB2 (collybistin II), and CB3 (hPEM2-like) and also
denotedSH3domainusage(e.g.,CB2SH3orCB2SH3).Inpost-
natal rodent spinal cord and brain, our RT-PCR assays predict
that the CB2SH3 and CB3SH3 isoforms are predominant (Fig.
1B,C). CB1 isoforms were not detected in any of our rodent
mRNAs but might be expressed in different tissues or at other
developmental stages. To confirm these results, we cloned and
sequenced full-length cDNAs for rat collybistin from rat whole-
brainmRNA.OnlyCB2SH3andCB3SH3cDNAswerefoundin
a ratio of 5:4 (nine independent isolates). In human brain and
spinal cord, only the CB3SH3 isoform was present; transcripts
encodingCB1andCB2variantswerenotdetected(Fig.1C).Last,
BLAST analysis revealed that rat collybistins and hPEM-2 are
most closely related to ARHGEF4 (ASEF/KIAA1112) (Kawasaki
etal.,2000),Tiam-1(Habetsetal.,1994;Worthylakeetal.,2000),
and PIX/p85Cool-1 (Bagrodia et al., 1998; Manser et al., 1998),
all of which specifically activate the GTPase Rac1 but not Cdc42.
Functional domains of collybistin required for gephyrin
submembrane targeting
Full-lengthcDNAsforCB2SH3andCB3SH3(supplementalFig.
1, available at www.jneurosci.org) were tagged with the 9E10
epitope at the N terminus of the expressed protein. To test the
activityoftheserecombinantcollybistinisoforms,wealsocreated
aplasmidconstruct(pEGFP-gephyrin)inwhichEGFPisfusedto
theNterminusofgephyrin(P1isoform)(Prioretal.,1992).This
allows discrimination of living cells possessing extensive sub-
membrane microaggregates from those showing intracellular
gephyrin deposits (Kins et al., 2000) using fluorescence micros-
copy. When transfected into HEK293 cells, myc-CB2SH3 is dif-
fusely distributed throughout the cytoplasm (Fig. 1E). Although
they were not serum-starved, some cells showing high levels of
myc staining exhibited filopodia (MacKay and Hall, 1998),
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contrast, EGFP-gephyrin expression resulted in the formation of
large intracellular deposits (Fig. 1F), which are consistent with
those observed using nontagged gephyrin (Kirsch et al., 1995).
CoexpressionofCB2isoformswithEGFP-gephyrinrevealedthat
the common SH3-containing variant (myc-CB2SH3) behaved
exactly like collybistin I (Kins et al., 2000) and redistributed to
large intracytoplasmic EGFP-gephyrin aggregates (Fig. 1G). In
contrast, the variant lacking the SH3 do-
main (myc-CB2SH3), redistributed with
EGFP-gephyrin to submembrane micro-
aggregates in 40% of cotransfected cells
(Fig. 1H,I), whereas others demonstrated
different phenotypes (e.g., intracellular
aggregates with extended filamentous
structures; data not shown). Transfection
of HEK293 cells with myc-CB2SH3,
EGFP-gephyrin and red fluorescent
protein-conjugated GlyR  subunit intra-
cellular loop (DsRed-GlyR ) resulted in
collybistin-mediated translocation of
EGFP-gephyrin to submembrane clusters
thatwerealsodecoratedbyDsRed-GlyR
(Fig. 2A–D). However, it is noteworthy
that the expression of myc-CB2SH3 was
not restricted to EGFP-gephyrin/DsRed-
GlyR  clusters (Fig. 2C,D).
Functional analyses of collybistin
isoforms and mutants in
transfected neurons
To assess the possible contribution of col-
lybistin to endogenous gephyrin cluster-
ing, we transfected selected collybistin
constructs into cultured cortical neurons.
Although collybistin has been speculated
to represent a synaptic protein (Kins et al.,
2000; Kneussel and Betz, 2000), we found
myc-CB2SH3 and myc-CB2SH3 to be
diffusely distributed throughout the soma
and dendrites of transfected cortical neu-
rons (Fig. 3A–D). Recombinant myc-
CB2SH3 and myc-CB2SH3 did not sig-
nificantly affect endogenous gephyrin
clustering (Fig. 3E). For myc-CB2SH3 the
average number of gephyrin clusters was
9.96  2.13 per 40 m segment per cell
versus 9.86  2.27 for myc-CB2SH3 (n  11 neurons per con-
struct). The average cluster size was 1.60  0.84 m for myc-
CB2SH3 versus 1.39  0.47 for myc-CB2SH3 (n  11 neurons
per construct). We next attempted to construct dominant-
negativemutantsofCB2(Fig.3,inset)totesttheproposedfunc-
tionofcollybistiningephyrinclusteringinneurons.Deletionsof
the RhoGEF domain (amino acids 114–293) or the PH domain
(amino acids 326–432) were made in the CB2SH3 isoform. On
expression in HEK293 cells, deletion of the RhoGEF domain
(myc-CB2SH3 RhoGEF) abolished gephyrin-collybistin colo-
calization and EGFP-gephyrin submembrane targeting (Fig.
3F,G). In contrast, deletion of the PH domain in myc-CB2SH3
(i.e.,myc-CB2SH3PH)resultedintheproductionofcytoplas-
mic collybistin-gephyrin aggregates (Fig. 3H,I), indicating that
thePHdomainwasrequiredfornormaltargetingofthisprotein.
As expected, myc-CB2SH3 PH also interfered effectively with
clustering of gephyrin in neurons: dendritic clusters of endoge-
nous gephyrin (as visualized by immunostaining with mAb7a)
were almost completely eliminated after expression of this dele-
tionmutant(Fig.3J,K).Theaveragenumberofgephyrinclusters
for myc-CB2SH3 PH was significantly reduced to 2.1  1.13
clusters per 40 m segment per cell (n  10 neurons) (Fig. 3E),
when compared with either myc-CB2SH3 or myc-CB2SH3
( p 	 0.001; Student’s t test). Thus, myc-CB2SH3 PH effec-
Figure1. AlternativesplicingofratandhumancollybistinmRNAs.ThreedifferentcollybistinCterminicanbespecifiedinthe
ratbytheuseofdifferentcassetteexons.Forexample,theCB2(VTQRKWHY*)Cterminusisgeneratedbyinsertionofa62bpexon
(A,whiteletteringonblackbackground).Whenomitted,analternativeCterminusisspecified(CB3)thatisvirtuallyidenticalto
theCterminusofhumancollybistin(hPEM-2).RT-PCRanalysisshowsthattheexonencodingtheN-terminalSH3domain(B)is
usedinmostrodentandhumancollybistinmRNAs(E, SH3;▫, SH3).ForC-terminalexons(C),bothCB2(E)andCB3(▫)are
commoninrodents,butonlyCB3transcriptsareevidentinhumans.D,Schematicdiagramoftheprimarystructuresofknown
collybistinisoforms.SequencesencodingtheSH3,RhoGEF,andPHdomainsinthecollybistinisoformsareindicatedbygrayboxes,
andthedifferentCterminiareindicatedbywhite(CB1),black(CB2),orgray(CB3)boxes.E,Expressionofmyc-taggedCB2SH3in
HEK293cells.F,G,CotransfectionofaplasmidconstructencodingEGFP-gephyrinresultsintheformationofcytoplasmicaggre-
gates (F) to which myc-CB2SH3 targets (G). However, coexpression of EGFP-gephyrin with the CB2 variant lacking the SH3
domain (myc-CB2SH3) results in a redistribution of EGFP-gephyrin and collybistin to submembrane microaggregates (H, I).
Scalebar,10m.NotethatE–GaresingleZ-planeconfocalimages,whereasHandIareZ-stacksatthecellsurface.
Figure2. ADsRed-GlyRfusionproteinisefficientlytargetedtoEGFP-gephyrinaggregates
inHEK293cells.Z-stackconfocalimagesshowingtripletransfectionofHEK293cellswithplas-
mid constructs encoding a DsRed-GlyR  subunit intracellular loop fusion protein (A; DsRed-
GlyR),EGFP-gephyrin(B),andmyc-CB2SH3(C).NotethatDsRed-GlyRisreadilytrapped
byEGFP-gephyrinsubmembraneclusters,whereasmyc-CB2SH3hasamorediffusedistribu-
tionpatternthroughoutthecytoplasm(D).Scalebar,10m.
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tinforbindingtogephyrin,causingmislo-
calization of endogenous gephyrin (Fig.
3J,K,arrows).Notethatdendritesofnon-
transfected control cells demonstrated ro-
bust gephyrin clustering (Fig. 3J).
Mapping of binding sites for collybistin
and the GlyR subunit on gephyrin
Althoughthebindingsitesforgephyrinon
collybistin and the GlyR  subunit have
been described previously (Kneussel et al.,
1999a;Grosskreutzetal.,2001),thecorre-
sponding binding sites on gephyrin have
remainedelusive.Severalstudieshavesug-
gested that the binding site for the GlyR 
subunit lies within the N-terminal MogA
domain (Meier et al., 2000; Schwarz et al.,
2001; Xiang et al., 2001) or the “linker re-
gion” of gephyrin (Prior et al., 1992).
However,thesestudiesarecomplicatedby
the fact that the MogA domain forms tri-
mers (Sola et al., 2001; Schwarz et al.,
2001), whereas the C-terminal MoeA do-
main probably dimerizes in a manner simi-
lar to the E. coli MoeA protein (Schrag et al.,
2001; Xiang et al., 2001). To define the re-
gions involved in collybistin-gephyrin and
GlyR -gephyrin interactions, we used the
GAL4 yeast two-hybrid system (Fields and
Song, 1989). Full-length rat gephyrin (P1
isoform) (Prior et al., 1992) interacted
readily with baits for CB2SH3 and the large
intracellularloopofthehumanGlyR sub-
unit(Reesetal.,2003)(Fig.4A).N-terminal
truncations of gephyrin lacking the MogA
domain and the linker region revealed nor-
malinteractionwiththeGlyR-subunitbait
(deletions 92, 184, 276, 305, and 323) (Fig.
4A). The same gephyrin constructs, except
deletion 323, also showed normal interac-
tionwiththeCB2SH3bait(Fig.4A,B).This
findingissignificant,becausetheGlyRbait
showsastronginteractionwithdeletion323,
indicating that this gephyrin fragment is indeed expressed in yeast
(Fig.4A,B).DeletionsateitherendoftheMoeAhomologydomain
of gephyrin (deletions 336, 643, 674, or 704) abolished both
CB2SH3 and GlyR  subunit interactions. A bait corresponding to
the MoeA homology domain of gephyrin revealed that although
deletions 305 and 323 showed strong MoeA–MoeA interactions
(Fig. 4B), deletions 336, 643, 674, and 704 either impaired or abol-
ished MoeA–MoeA multimerization.
Becausedeletions305and323appearedtodemarcatearegion
important for collybistin-gephyrin interactions, we used an ala-
ninemutationscanacrossthisregiontofurtherdefinetheamino
acids involved. This revealed that mutants A4 and A5, which
together span the short peptide sequence PFPLTSMDKA (Fig.
4C,D),disruptedcollybistin-gephyrininteractionswithoutaffecting
the GlyR -gephyrin interaction. It is noteworthy that the P-F-P
motif at the beginning of the putative collybistin-binding motif is
lost in the deletion construct 323 (Fig. 4D). Mutation of residues
flanking the PFPLTSMDKA motif (mutants Geph-A3 and Geph-
A6) did not affect collybistin-gephyrin or GlyR -gephyrin interac-
tions in yeast (Fig. 4C,D). To test whether the A4 and A5 alanine
mutants disrupted collybistin-gephyrin colocalization in mamma-
liancells,wenextintroducedthesemutationsintopEGFP-gephyrin.
These mutations were sufficient to either disrupt (EGFP-GephA4)
or severely weaken (EGFP-GephA5) collybistin-gephyrin colocal-
ization (Fig. 4E) after coexpression with myc-CB2SH3 in HEK293
cells. In addition, submembrane targeting was abolished for both
EGFP-A4 and EGFP-A5 (Fig. 4E).
Expression of EGFP-gephyrin in transfected cortical neurons
resulted in punctate staining throughout dendritic processes
(Fig. 5A), which colocalizes with staining for mAb7a (gephyrin)
and GAD (Fig. 5E). However, when neurons were transfected
with the EGFP-GephA4 mutant, dendritic puncta were dramat-
icallyreduced.Twomainphenotypeswerenoted:eithergephyrin
accumulated in large aggregates in the cell soma (Fig. 5B) or cell
somaplusdendrites(Fig.5C).Thesegephyrinaggregateswereno
longer juxtaposed to GABAergic terminals (Fig. 5F,G). There-
fore, EGFP-GephA4 acts as a dominant-negative factor trapping
endogenous gephyrin and preventing proper apposition of pre-
Figure3. Functionalcollybistinisrequiredforaccumulationofgephyrinindendriticclusters.A–E,Expressionofmyc-tagged
CB2SH3(A,C)andCB2SH3(B,D)isoformsintransfectedmousecorticalneuronsrevealsadiffusedistributionthroughoutthe
cellsomaanddendrites(seeenlargementsinCandD)withoutaffectinggephyrinclusternumber(E;valuesaremeanSE).
ConstructslackingtheRhoGEForPHdomains(inset)werecoexpressedwithEGFP-gephyrininHEK293cells.F,G,SingleZ-plane
confocal images show that myc-CB2SH3 RhoGEF mutant no longer colocalizes with EGFP-gephyrin and prevents submem-
branetargeting.H,I,Incontrast,themyc-CB2SH3PHmutantcolocalizeswithEGFP-gephyrinbutalsoresultsintheproduction
ofcytoplasmiccollybistin-gephyrinmicroclusters.NotethatgephyrinandcollybistinaggregatesinF–Iareintracellular,because
thecellnucleusisclearlyvisibleineachsingleopticalsection.J,K,Intransfectedmousecorticalneurons,myc-CB2SH3PHacts
as a dominant-negative factor, competing with endogenous collybistin for binding sites on gephyrin. Quantitative analysis of
mAb7astainingindicatesastatisticallysignificantlossofdendriticgephyrinclusters(E;*p	0.001;Student’sttest;n10–11
cellsperconstruct)andaccumulationofendogenousgephyrininaggregatesintheproximaldendrites(whitearrow).Scalebars:
A,B,22m;C,D,11m;F–I,5m;J,23m;K,11.5m.
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GephA5 shows a few large dendritic clusters and appears to trap
endogenous gephyrin at these sites (Fig. 5D,H). Quantitative
analysis (Fig. 5I) demonstrated that the average endogenous
gephyrin cluster number (mAb7a immunofluorescence) was re-
duced to 2  1.95 clusters per 40 m segment per cell for EGFP-
GephA4 (n  12 neurons) and 4.63  2.01 clusters for EGFP-
GephA5 per 40 m segment per cell. These results were
statistically significant when compared with EGFP-gephyrin,
which showed an average of 9.77  2.74 clusters per 40 m
segment per cell (n  13 neurons; p 	 0.001; Student’s t test). In
summary, both EGFP-GephA4 and EGFP-GephA5 mutants ef-
fectively interfere with clustering of endogenous gephyrin in
transfected cortical neurons. As in HEK293 cells (Fig. 4E), mu-
tant EGFP-GephA4 is particularly effective, leading to a fivefold
reduction of endogenous gephyrin clusters.
ARHGEF9as a candidate gene
for hyperekplexia
Hereditaryhyperekplexiaisaneurological
disorder characterized by an excessive
startle response, which can be caused by
diverse dominant and recessive mutations
in the genes encoding the GlyR 1
(GLRA1) (Rees et al., 2001) or  subunits
(GLRB)(Reesetal.,2002).However,asig-
nificant portion of patients with hyperek-
plexia does not appear to have mutations
ineitherGLRA1(Vergouweetal.,1997)or
GLRB (Rees et al., 2002), suggesting that
other components of the GlyR signaling
complex, such as gephyrin (GPHN) (Rees
et al., 2003) and collybistin (gene symbol:
ARHGEF9) may be involved. ARHGEF9
consistsof10exonsdistributedover190
kb of human chromosome Xq22.1 (Fig.
6A; supplemental Table 1, available at
www.jneurosci.org).ESTanalysisrevealed
the existence of two alternative first exons
(denoted exons 1a and 1b) (supplemental
Table 1, available at www.jneurosci.org),
suggesting that ARHGEF9 has two pro-
moters that might control tissue-specific
or developmentally regulated changes in
geneexpression.Exon1aencodesalongN
terminus (MQWIRGGSGM), whereas
exon 1b encodes a shorter sequence
(MTL). Exons 1a and 1b do not appear to
influence utilization of exon 2, which en-
codes the SH3 domain (data not shown).
We used PCR (primers listed in sup-
plemental Table 2, available at www.
jneurosci.org) and automated dHPLC to
detectARHGEF9mutationsandpolymor-
phismsinacohortof32hyperekplexiapa-
tients. Two SNPs were detected in the in-
tronic regions of exon 1b (IVS2  43 tc;
het  0.05) and exon 10 (IVS11  64 tc;
het  0.04) in both male and female pa-
tients and control cohorts. Significantly, a
missense mutation (G164C) in the ARH-
GEF9codingregionwasdiscoveredinone
patient, which causes a glycine to alanine
(G55A) substitution at position 55 of
hPEM-2(Fig.6B,C,inset).ThemutantgenotypecreatesaNlaIII
restriction site (5-GATG-3 to 5-CATG-3), a situation which
was not detected in over 200 unrelated Caucasian control chro-
mosomes (Fig. 6D). A glycine residue is found at the equivalent
position in 97% of known SH3 domains (2580/2669) as assessed
by using psiBLAST (www.biology.wustl.edu/gcg/psiblast.html)
against the National Center for Biotechnology Information non-
redundant database. A molecular model of the SH3 domain
structure (Fig. 6E) shows that the G55A substitution lies in the
middle of a  strand, and that this position of the protein back-
bonehasPhi/Psianglesjustbeyondthelimitsofwhatisnormally
allowed for a nonglycine amino acid. G55A lies proximal to one
of a series of residues that has been implicated in binding the
proline-rich motif (Fig. 6B).
The patient was the first-born child of a 32-year-old woman,
delivered in the thirty-sixth week of gestation. Immediately after
Figure4. Mappingofthecollybistinbindingsiteongephyrin.A,DeletionconstructsoftheratgephyrinP1isoforminpACT2
(Clontech)weretestedusingtheGlyRsubunitintracellularloop()andfull-lengthcollybistinCB2SH3isoform(CB2)asbaits.
Bothproteinsinteractwithfull-lengthgephyrininyeast,asjudgedbyasemiquantitativeLacZassay(,stronginteraction;
,weakinteraction;—,nointeraction).DeletionanalysisindicatedthatthegephyrinMogAdomain(MogA)andmostofthe
linkerregiondonotappeartocontributetoeitherGlyRsubunitorcollybistinbinding.DeletionsintothegephyrinMoeAdomain
(MoeA)destroyinteractionswithbothcollybistinandtheGlyRsubunitbecauseofthelossofMoeA–MoeAdomaininteractions.
B,Geph-305interactswithGlyR,CB2SH3,andMoeAdomainbaits,whereasGeph-323(whichcorrespondstoaMoeAdomain
prey)interactswithGlyRandMoeAbutnotCB2SH3.C,D,Mutants(Geph-A1toGeph-A7),whichspantheGeph-305toGeph
323region,werethenconstructedandtestedinyeastassays.MutationsGeph-A4andGeph-A5(boxed)abolishedinteractions
with CB2SH3 but not the GlyR  subunit (C, D). The corresponding mutants in EGFP-gephyrin eliminated (EGFP-GephA4) or
weakened (EGFP-GephA5) colocalization with myc-CB2SH3 (E) and blocked submembrane microaggregate formation. Scale
bar,10m.
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(suggestive of muscular hypertonia) were
noted. The child also appeared to stare.
During the following weeks, the child de-
veloped tonic seizures that were provoked
by tactile stimulation. To counter the sei-
zures, initially phenobarbital and then la-
motrigene were administered. Although
the latter treatment was initially effective,
afterthreeandone-halfmonthsofage,the
seizures recurred and were often precipi-
tatedbyextremeemotions.At4monthsof
age, a diagnosis of hyperekplexia was
made, but therapy with clonazepam was
unsuccessful. EEG monitoring coupled
with ambulatory video revealed that the
seizures were both hyperekplectic and ep-
ileptic in origin. During the following
years, the child suffered from frequent
long-lasting seizures, accompanied by the
arrest and later decline of psychomotor
development. Eventually, a progressive
epileptic encephalopathy as well as hy-
perekplexiabecameevidentandpoly-drug
treatmentfailedtoprovideadequatelong-
term seizure control. At four years of age,
the subject was severely retarded and suf-
fered almost daily severe long-lasting fits
both epileptic and nonepileptic in origin,
eventually leading to death at the age of 4 years and 4 months.
Functional analysis of the G55A mutation
The clinical symptoms above are consistent with a mislocaliza-
tion of neuronal gephyrin and associated glycine and GABAA
receptors.Wethereforeassessedpossiblefunctionalconsequencesof
the G55A mutation. Unlike myc-CB2SH3 (Fig. 1G) or myc-
CB3SH3(Fig.6F),myc-CB3SH3G55Adidnotcolocalizewithlarge
cytoplasmicEGFP-gephyrinaggregatesintransfectedHEK293cells,
but like myc-CB2SH3 (Fig. 1I), myc-CB3SH3G55A translocated
gephyrin to submembrane microaggregates (Fig. 6G). This result
suggeststhattheG55AmutationdisruptstheSH3domainstructure
and function. In cortical neurons, wild-type myc-CB3SH3 is dif-
fusely expressed within the soma and proximal and distal dendrites
and does not influence endogenous gephyrin clustering (Fig. 6H–
J,Q). The average gephyrin cluster number was 11.9  4.44 per 40
mdendriticsegment(n11neurons)formyc-CB3SH3.Incon-
trast, myc-CB3SH3G55A forms a tight association with endoge-
nousgephyrinandisconfinedtothecellsomaandproximalden-
drites, indicating a deficit in dendritic trafficking of this mutant
protein (Fig. 6K–M). In another subset of cells, myc-
CB3SH3G55Aisfoundinlargesomaticanddendriticaggregates
(Fig.6N–P),whichresultsinanalmostcompletelossofgephyrin
clusters. Quantitative analysis of gephyrin clustering shows that
expression of myc-CB3SH3G55A results in a dramatic loss of
endogenous gephyrin clusters (Fig. 6Q). The average cluster
number (mAb7a immunofluorescence) was reduced to 1.55 
0.72clustersper40msegmentpercellformyc-CB3SH3G55A,
which is statistically significant compared with myc-CB3SH3
(n  11 cells per construct; p 	 0.001; Student’s t test).
Toaddresspossiblefunctionalconsequencesatinhibitorysynapses,
we assessed whether transfection of myc-CB3SH3G55A would affect
postsynaptic localization of GABAA receptors. Triple staining of
neurons transfected with myc-CB3SH3 with antibodies specific
forthisconstruct,forGABAterminals(GAD)andfortheGABAA
receptor 2 subunit revealed, as expected, diffuse distribution of
thiscollybistinisoformandproperlocalizationofGABAArecep-
torsatpostsynapticsites(Fig.7A–D).Enlargementofadendritic
segment(Fig.7E–H)showsclearcolocalizationofGABAArecep-
tors (red) and GAD (blue) resulting in purple puncta (Fig. 7H,
arrows). In contrast, in neurons transfected with myc-
CB3SH3G55A, GABAA receptors were essentially absent from
the dendritic compartment (Fig. 7I–P). Quantitative analysis of
GABAAreceptorclustering(Fig.7Q)showsthattheaverageclus-
ter number was reduced to 2.08  1.29 clusters per 40 m seg-
mentpercellformyc-CB3SH3G55A,whichisstatisticallysignif-
icant when compared with 10.04  1.57 clusters for myc-
CB3SH3 (n  12 cells per construct; p 	 0.001; Student’s t test).
This mislocalization of GABAA receptors, together with a corre-
sponding expected deficit in glycine receptor trafficking in brain
stemandspinalcordneurons,islikelytobecausalfortheclinical
phenotype of the patient described above.
Discussion
The dendritic trafficking of receptors and clustering at appropri-
ate sites in the postsynaptic membrane are extremely important
eventsintheformationoffunctionalsynapses.Thisstudyreveals
that the RhoGEF collybistin is a key molecule in regulating syn-
aptic localization of gephyrin and by association, GABAA and
glycine receptors. First, we reported the characterization of new
variantsofcollybistin,whicharecreatedbyalternativesplicingof
exons encoding an N-terminal src homology 3 domain and three
alternate C termini (CB1, CB2, and CB3). Secondly, we have
shown that the SH3 domain negatively regulates the ability of
collybistin to translocate gephyrin to submembrane microaggre-
gates in HEK293 cells. Because most endogenous collybistin iso-
forms harbor this region, this strongly suggests that collybistin
activity is regulated by protein–protein interactions at the SH3
Figure5. Disruptionofthecollybistinbindingsiteongephyrinpreventsaccumulationofgephyrinatpostsynapticsites.A–H,
EGFP-taggedgephyrin(A,E)andthemutantsEGFP-GephA4(B,C,F,G)andEGFP-GephA5(D,H)weretransfectedintocortical
neuronsandthecellsimmunostainedforgephyrin(mAb7a;A–D)orGAD(mAbGAD-6;E–H).Twoexamplesofcellsareshownfor
EGFP-GephA4representingcomparativelylow(B,F)andhigh(C,G)levelsofexpressionandcorrespondingaggregatepheno-
types. Note the perfect colocalization of transfected EGFP-gephyrin with endogenous gephyrin in yellow puncta (A). The few
remainingredpunctaindicateendogenousgephyrinexpressedondendritesofnontransfectedneighboringcellsthatarethere-
fore not colocalized with EGFP-gephyrin. EGFP-gephyrin is localized at postsynaptic sites juxtaposed to presynaptic GAD (E,
arrows).MutantsEGFP-GephA4andEGFP-GephA5formlargeaggregatesinthesomaanddendrites,whicharenolongerjuxta-
posedtoGABAergicterminals(F–H).Endogenousgephyrinhasbeentrappedintheseextrasynapticgephyrinmutantaggregates,
whichthereforeappearyellow(B–D).QuantitativeanalysisofmAb7astainingindicatesastatisticallysignificantlossofsynaptic
gephyrinclusters(I;*p	0.001;Student’sttest;n12–13cellsperconstruct)fortheEGFP-GephA4andEGFP-GephA5mutants
comparedwithEGFP-gephyrin.Scalebar,20m.
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because gephyrin clustering requires both collybistin-gephyrin
interactions and an intact collybistin PH domain. Third, we
mapped the binding sites for collybistin and the GlyR  subunit
on gephyrin to the C-terminal MoeA homology domain and
showthatmultimerizationoftheMoeAdomainisarequirement
for both collybistin-gephyrin and GlyR-gephyrin interactions.
Last, we present the first significant genetic evidence that col-
lybistin is important for the correct synaptic targeting of
gephyrin:aG55Amutationinexon2ofthehumancollybistin
gene(ARHGEF9)resultsinsymptomsof
both hyperekplexia and epilepsy, which
is likely to be caused by mislocalization
of gephyrin and associated GlyR and
GABAA receptors.
Functional significance of collybistin
alternative splicing
In addition to the original rat collybistin
isoforms (now denoted CB1SH3 and
CB2SH3), we cloned two additional iso-
forms (CB2SH3 and CB3SH3) from neo-
natal rat brain. We also determined that
the CB2 and CB3 isoforms are of equal
abundanceinpostnatalratormousebrain
(CB1 was not detected), and that in adult
human spinal cord and brain, CB3SH3
(butnotCB1orCB2)wasdetected.Alterna-
tive splicing of N- and C-terminal exons in-
dicates that care must be applied in inter-
preting studies using in situ hybridization
(Kins et al., 2000; Kneussel et al., 2001a) or
when generating collybistin-specific anti-
sera. The finding that CB2SH3 and
CB3SH3arefunctionallyinactiveinrecom-
binant gephyrin clustering assays is a para-
dox, because the vast majority of spliced
transcripts in rat, mouse, and human spinal
cord or brain clearly seem to encode these
isoforms.Itappearsthatcollybistinactivityis
regulatedviaprotein–proteininteractionsor
post-translational modifications at the SH3
domainandthatthismechanismonlyoper-
ates correctly in neurons. In this model, col-
lybistin could be “activated” at specific sub-
cellular locations by an SH3-interacting
ligand or “trigger protein.”
Functional collybistin is required for
dendritic clustering of gephyrin
Byoverexpressingrecombinantcollybistin
isoforms and mutants in cortical neurons,
we demonstrated that collybistin is an es-
sential molecule for dendritic gephyrin
clustering and for appropriate trafficking
of GABAA receptors to synapses. A similar
role for collybistin is likely at glycinergic
synapses of brainstem and spinal cord
neurons. The distribution of epitope-
tagged collybistin in neurons suggested
that the protein is present at, but not lim-
ited to, synaptic sites. Analyses of the ex-
pression pattern of the PH domain dele-
tion mutant, CB2SH3 PH, suggested
that collybistin is involved in dendritic transport of gephyrin to
inhibitorysynapses.DeletionofthePHdomainresultedinaccu-
mulationofendogenousgephyrininproximaldendritesandsig-
nificantlyreducedendogenousgephyrinclustering.Whetherthis
mutation disrupts PH domain-membrane phosphoinositide
interactions, or the binding of one or more key collybistin-
interacting proteins, remains to be determined. The RhoGEF
domain deletion also disrupted submembrane targeting of
gephyrin; this is likely because of the fact that CB2SH3 Rho-
Figure6. MutationofG55Ainapatientwithhyperekplexiaandepilepsy.A,Genomicstructureofthehumancollybistingene
(ARHGEF9)encodinghPEM-2.B,ThelocationofthemutationG55A(redlettering)intheN-terminalSH3domain(underlined)of
hPEM-2isshown.G55Aliesproximaltooneoftheseriesofresiduesthathavebeenproposedtobindproline-richmotifs(blue
lettering).C,DNAsequencingofexon2samplesrevealedaGtoCsubstitutionatposition164ofthecollybistincodingsequence,
causingaG55AmissensemutationintheN-terminalSH3domainofhPEM2.G164,Controlsample;G164G164C,ad-mixtureof
thepatientsamplewithafemaleDNAcontrol;G164C,G164Cmutation.D,Restrictionfragmentlengthpolymorphismanalysisof
theG55Amutation:theG164CmutationcreatesanovelNlaIIIsiteatposition207ofthe313bpexon2PCRfragment.This,in
conjunctionwithanotherNlaIIIsiteatposition106,generatesconvergentfragmentsof106,101,and106bpinthepatientDNA
sample(denotedP).Normalcontrols(C1–C4)havefragmentsof207and106bp.E,Amolecularmodelshowingthelocationof
G55intheSH3domainstructurecalculatedwithSwiss-Model(GuexandPeitsch,1997).F,G,ConfocalimagesshowingHEK293
cellstransfectedwithplasmidconstructsformyc-CB3SH3andEGFP-gephyrin(F)ormyc-CB3SH3G55AandEGFP-gephyrin(G).
Notethatmyc-CB3SH3colocalizeswithcytoplasmicEGFP-gephyrinaggregates,whereasmyc-CB3SH3G55Aresultsinsubmem-
branemicroclustersofEGFP-gephyrin.H–P,Confocalimagesshowingmyc-CB3SH3(H–J)andmyc-CB3SH3G55A(K–P)ex-
pressedinculturedcorticalneurons.Althoughwild-typemyc-CB3SH3(H)isexpressedthroughoutthecellsomaanddendrites
and does not disrupt gephyrin localization (H–J), myc-CB3SH3G55A forms a tight association with endogenous gephyrin in
clustersconfinedtoproximaldendrites(K–M).Inasubsetoftransfectedcells(N–P),myc-CB3SH3G55Aformslargesomaticand
dendriticaggregates,whichresultsinanalmostcompletelossofgephyrinclusters.RemainingredpunctainI,L,andOrepresent
gephyrinclustersfromnontransfectedcellsinthesameculture.QuantitativeanalysisofmAb7aimmunofluorescence(Q)indi-
catesadramaticlossofgephyrinclusters(*p	0.001;Student’sttest;n11cellsperconstruct)formyc-CB3SH3G55Amutant
comparedwithmyc-CB3SH3.Scalebars:F,G,10m;H–P,35m.
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rather than deficits in GDP-GTP exchange.
Interaction of collybistin and GlyR
with gephyrin requires
MoeA–MoeA interactions
A C-terminal fragment encompassing
amino acids 305–736 of gephyrin dis-
played robust binding to collybistin and
gephyrin, meaning that all of the
N-terminal MogA homology domain
(amino acids 16–169) and most of the in-
tervening linker region (amino acids 170–
322) are dispensable for binding these
molecules. Furthermore, our results
with deletion constructs indicated that
the binding site for GlyR  must reside
entirely within the MoeA homology do-
main (amino acids 323–736). If the
gephyrin MoeA homology domain
forms an antiparallel dimer, like E. coli
MoeA (Mene ´ndez et al., 1997; Schrag et
al., 2001; Xiang et al., 2001), our results
strongly suggest that two equivalent
GlyR  binding sites would be present at
the MoeA–MoeA homology domain in-
terface.Whetherthesetwoequivalentsites
wouldbindasingleGlyRheteromer,whichisthoughttocontain
two  subunits (stoichiometry 132) or two distinct receptor
pentamers, is presently unclear. Localization of the residues on
gephyrinthatinteractwithGlyRswillprobablyrequirecocrystal-
lization of the MoeA homology domain with a peptide corre-
sponding to the gephyrin-binding site on the GlyR  subunit
(Kneusseletal.,1999a).Cautionmustbeexercisedwiththeanal-
ysis of mutants that disrupt gephyrin-GlyR  subunit interac-
tions, because these may simply be defective in MoeA–MoeA
assembly. Ideally, a gephyrin mutant defective in GlyR  subunit
binding would retain robust MoeA–MoeA interactions and
would be translocated to submembrane microaggregates by
collybistin.
A putative binding site for collybistin was located to the bor-
der of the linker region and MoeA domain. Replacement of two
adjacent groups of five amino acids either completely abolished
(Geph-A4)orreduced(Geph-A5)collybistin-gephyrininteractions
in HEK293 cells but did not affect interaction with the GlyR  sub-
unit. When expressed in cortical neurons, EGFP-gephyrin was lo-
calizedatsynapticsites.Thiswasevidencedbythealmostperfect
concordanceofEGFP-gephyrinfluorescenceandmAb7aimmu-
noreactivity, the latter representing both transfected and endog-
enous gephyrin and bytheclose apposition of EGFP-gephyrin and
presynaptic immunoreactivity for GAD. In contrast, the gephyrin
A4 and A5 mutants were both confined to large somatic and den-
driticaggregates.TheseaggregateswerenotapposedtoGADimmu-
noreactivity, indicating they were mislocalized. Quantitative analy-
ses showed that punctate immunoreactivity for endogenous
gephyrin in these transfected cells was severely reduced for EGFP-
GephA4 and, to a lesser extent, for EGFP-GephA5. Interestingly, in
cellsexpressinghighlevelsoftheEGFP-GephA4mutant,themutant
and endogenous gephyrin proteins were both confined to large
structures that extended far into peripheral dendrites. Thus,
EGFP-GephA4 is effectively transported to peripheral den-
drites, although it cannot by itself interact with colly-
bistin.However,somecollybistin-dependenttraffickingfunc-
tion may be provided indirectly through multimerization of
the mutant gephyrin construct with endogenous gephyrin,
which remains likely to interact with collybistin. In compari-
son, EGFP-GephA5 aggregates were smaller and more con-
fined to the soma and proximal dendrites of transfected neu-
rons. Our study identifies a critical sequence in gephyrin
(PFPLTSMDKA) that appears to be essential for collybistin-
gephyrin interactions and for normal collybistin-mediated
trafficking and clustering of gephyrin to postsynaptic sites.
G55A mutation in the hPEM2 SH3 domain leads to
hyperekplexia and epilepsy
The importance of collybistin for postsynaptic localization of
gephyrinandassociatedligand-gatedchloridechannelsisunder-
lined by the effect of the G55A mutation in the SH3 domain,
leading to symptoms of both hyperekplexia and epilepsy. Recent
studies(Douangamathetal.,2002;Groempingetal.,2003;Liuet
al., 2003) have shown that there is sometimes binding of ligands
toSH3domainsbeyondtheproline-richpeptidebindingregion.
However,becausetheconservedglycineisburiedwithintheSH3
domainstructure,weconsiderthatdisruptingSH3domainfold-
ing rather than the binding surface is the most probable mecha-
nism of action. This is supported by studies in transfected
HEK293cells,revealingthattheG55AmutationderegulatesSH3
domain-containing collybistin isoforms, allowing translocation
ofgephyrintosubmembranesitesinHEK293cells.However,itis
noteworthy that in neurons, myc-CB3SH3G55A differs dramat-
ically from other recombinant collybistin isoforms, including
myc-CB2SH3, which lacks the SH3 domain. CB3SH3G55A
forms a tight association with gephyrin in dendritic clusters or
formslargesomaticanddendriticaggregates.Thesefindingssug-
gest that the G55A mutation causes a more complex deficit in
dendritictraffickingofcollybistinanddisruptscollybistin–acces-
sory protein interactions. The severe functional consequences of
this mutation for the synaptic localization of gephyrin and, by
Figure7. CollybistinmutantCB3SH3G55AresultsinlossofGABAAreceptorclusters.Triplestainingofneuronstransfected
witheithermyc-CB3SH3(A–H)ormyc-CB3SH3G55A(I–P)withantibodiesagainsttheGABAAreceptor2subunits(red),myc
tag(green),andGAD(blue).Notethatinmyc-CB3SH3-transfectedneurons(A–D),GABAAreceptorclustersarejuxtaposedto
GAD-positiveterminals(aselecteddendriticregionisenlargedinimagesE–H).OverlapofGABAAreceptorandGADimmunore-
activityappearspinkinthemergedimage(H,arrows).Incontrast,inneuronsexpressingmyc-CB3SH3G55A,GABAAreceptor
immunoreactivity is primarily confined to the cell soma (I, M), and large collybistin aggregates (J, N) are observed throughout the
dendrites.NotethatthesecollybistinaggregatesarenotjuxtaposedtoGABAergicterminals(K,L,O,P).Quantitativeanalysisof2subunit
immunofluorescence(Q)indicatesastatisticallysignificantlossofGABAAreceptorclusters(*p	0.001;Student’sttest;n12cellsper
construct)forthemyc-CB3SH3G55Amutantcomparedwithmyc-CB3SH3.Scalebars:A–D,I–L,25m;E–H,M–P,12.5m.
5824 • J.Neurosci.,June23,2004 • 24(25):5816–5826 Harveyetal.•CollybistinandGephyrinClusteringassociation, GABAA receptors strongly suggest that the clinical
phenotype observed in this patient was a consequence of the loss
of gephyrin and major GABAA and GlyR subtypes from synaptic
sites. Although gene targeting experiments in mice have previ-
ously suggested that loss of gephyrin would be lethal in the first
postnataldays,gephyrinisnotonlyrequiredforsynapticcluster-
ingofGABAAandGlyRs(Fengetal.,1998;Kneusseletal.,1999b,
2001b; Levi et al., 2004) but also for molybdoenzyme activity in
non-neuronal tissues. Overall, we predict that mutations affect-
ingcollybistinfunctionresultinaneuronalgephyrinphenotype,
whereas peripheral molybdoenzyme-related functions of
gephyrin are left undisturbed. The possibility remains that
additional mutations in ARHGEF9 may contribute to other
cases of X-linked hyperekplexia and epilepsy.
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